Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 516783, 9 pages
http://dx.doi.org/10.1155/2015/516783
Research Article

Protective Effects of BDNF against C-Reactive Protein-Induced Inflammation in Women

Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA

Received 13 March 2015; Revised 11 May 2015; Accepted 14 May 2015

Academic Editor: Ariadne Malamitsi-Puchner

Copyright © 2015 Nicole Noren Hooten et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. K. Wenger, “Coronary heart disease in men and women: does 1 size fit all? No!,” Clinical Cardiology, vol. 34, no. 11, pp. 663–667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Mosca, E. J. Benjamin, K. Berra et al., “Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the american heart association,” Circulation, vol. 123, no. 11, pp. 1243–1262, 2011. View at Google Scholar
  3. A. Khera, D. K. McGuire, S. A. Murphy et al., “Race and gender differences in C-reactive protein levels,” Journal of the American College of Cardiology, vol. 46, no. 3, pp. 464–469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” The New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Kermani and B. Hempstead, “Hempstead, Brain-derived neurotrophic factor: a newly described mediator of angiogenesis,” Trends in Cardiovascular Medicine, vol. 17, no. 4, pp. 140–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Wagner, K.-D. Wagner, H. Theres, C. Englert, A. Schedl, and H. Scholz, “Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1,” Genes & Development, vol. 19, no. 21, pp. 2631–2642, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Donovan, M. I. Lin, P. Wiegn et al., “Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization,” Development, vol. 127, no. 21, pp. 4531–4540, 2000. View at Google Scholar · View at Scopus
  8. P. Kermani, D. Rafii, D. K. Jin et al., “Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 653–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Okada, M. Yokoyama, H. Toko et al., “Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1902–1909, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Jiang, Y. Liu, Y. Zhang, and Z.-Y. Chen, “Association of plasma brain-derived neurotrophic factor and cardiovascular risk factors and prognosis in angina pectoris,” Biochemical and Biophysical Research Communications, vol. 415, no. 1, pp. 99–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Manni, V. Nikolova, D. Vyagova, G. N. Chaldakov, and L. Aloe, “Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes,” International Journal of Cardiology, vol. 102, no. 1, pp. 169–171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Golden, A. Emiliano, S. Maudsley et al., “Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the baltimore longitudinal study of aging,” PLoS ONE, vol. 5, no. 4, Article ID e10099, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Ejiri, N. Inoue, S. Kobayashi et al., “Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease,” Circulation, vol. 112, no. 14, pp. 2114–2120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. H. Kim, S. J. Won, S. Sohn et al., “Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase,” Journal of Cell Biology, vol. 159, no. 5, pp. 821–831, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Noren Hooten, N. Ejiogu, A. B. Zonderman, and M. K. Evans, “Association of oxidative DNA damage and C-reactive protein in women at risk for cardiovascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 11, pp. 2776–2784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. K. Evans, J. M. Lepkowski, N. R. Powe, T. LaVeist, M. F. Kuczmarski, and A. B. Zonderman, “Healthy aging in neighborhoods of diversity across the life span (HANDLS): overcoming barriers to implementing a longitudinal, epidemiologic, urban study of health, race, and socioeconomic status,” Ethnicity and Disease, vol. 20, no. 3, pp. 267–275, 2010. View at Google Scholar · View at Scopus
  17. N. Noren Hooten, K. Kompaniez, J. Barnes, A. Lohani, and M. K. Evans, “Poly(ADP-ribose) polymerase 1 (PARP-1) binds to 8-oxoguanine-DNA glycosylase (OGG1),” Journal of Biological Chemistry, vol. 286, no. 52, pp. 44679–44690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. H. Morrell, J. D. Pearson, and L. J. Brant, “Linear transformations of linear mixed-effects models,” The American Statistician, vol. 51, no. 4, pp. 338–343, 1997. View at Google Scholar · View at Scopus
  19. R. D. C. Team, R: A language and environment for statistical computing, Foundation for Statistical Computing, Vienna, Austria, 2013, http://www.r-project.org/.
  20. E. S. Ford, W. H. Giles, A. H. Mokdad, and G. L. Myers, “Distribution and correlates of C-reactive protein concentrations among adult US women,” Clinical Chemistry, vol. 50, no. 3, pp. 574–581, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. T. A. Pearson, G. A. Mensah, R. W. Alexander et al., “Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association,” Circulation, vol. 107, no. 3, pp. 499–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. P. M. Ridker and N. Cook, “Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores,” Circulation, vol. 109, no. 16, pp. 1955–1959, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Pluchino, M. Russo, A. N. Santoro, P. Litta, V. Cela, and A. R. Genazzani, “Steroid hormones and BDNF,” Neuroscience, vol. 239, pp. 271–279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-L. Yang, Y.-T. Lin, P.-C. Chuang, V. A. Bohr, and M. P. Mattson, “BDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/apyrimidinic endonuclease 1,” NeuroMolecular Medicine, vol. 16, no. 1, pp. 161–174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Rothman, K. J. Griffioen, R. Wan, and M. P. Mattson, “Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health,” Annals of the New York Academy of Sciences, vol. 1264, no. 1, pp. 49–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. M. Rothman and M. P. Mattson, “Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan,” Neuroscience, vol. 239, pp. 228–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Helan, B. Aravamudan, W. R. Hartman et al., “BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia,” Journal of Molecular and Cellular Cardiology, vol. 68, pp. 89–97, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Prigent-Tessier, A. Quirie, K. Maguin-Gate et al., “Physical training and hypertension have opposite effects on endothelial brain-derived neurotrophic factor expression,” Cardiovascular Research, vol. 100, no. 3, pp. 374–382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Swardfager, N. Herrmann, S. Marzolini et al., “Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease,” Brain, Behavior, and Immunity, vol. 25, no. 6, pp. 1264–1271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. K. S. Krabbe, E. L. Mortensen, K. Avlund et al., “Brain-derived neurotrophic factor predicts mortality risk in older women,” Journal of the American Geriatrics Society, vol. 57, no. 8, pp. 1447–1452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. V. Halade, Y. Ma, T. A. Ramirez et al., “Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 12, pp. H1830–H1842, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Grad and H. D. Danenberg, “C-reactive protein and atherothrombosis: cause or effect?” Blood Reviews, vol. 27, no. 1, pp. 23–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Jiang, R. Wang, Y. Liu, Y. Zhang, and Z.-Y. Chen, “BDNF Val66Met polymorphism is associated with unstable angina,” Clinica Chimica Acta, vol. 400, no. 1-2, pp. 3–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Nettiksimmons, E. M. Simonsick, T. Harris, S. Satterfield, C. Rosano, and K. Yaffe, “The associations between serum brain-derived neurotrophic factor, potential confounders, and cognitive decline: a longitudinal study,” PLoS ONE, vol. 9, no. 3, Article ID e91339, 2014. View at Publisher · View at Google Scholar · View at Scopus